» Articles » PMID: 30366236

Barriers and Facilitators to Discontinuing Antidepressant Use: A Systematic Review and Thematic Synthesis

Overview
Journal J Affect Disord
Date 2018 Oct 27
PMID 30366236
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore patient and health professional views and experiences of antidepressant treatment with particular focus on barriers and facilitators to discontinuing use.

Design: Systematic review with thematic synthesis DATA SOURCES: MEDLINE, PubMed, Embase, PsycINFO, CINAHL, AMED, Health Management Information Consortium, OpenGrey, and the Networked Digital Library of Theses and Dissertations from inception until February 2017. Updated searches were carried out in July 2018.

Eligibility Criteria: Primary studies, published in English, that used qualitative data collection and analysis, and had data on attitudes, beliefs, feelings, perceptions on continuing or discontinuing antidepressant use, of patients (aged 18 or above, who received treatment with antidepressants for at least 6 months) or any health professionals.

Data Extraction: One reviewer extracted data and assessed study quality, which was checked by a second reviewer.

Findings: Twenty two papers were included in the review. A thematic synthesis was performed for patient perspectives only, due to insufficient data from a health professional perspective. The thematic synthesis yielded nine themes: (1) psychological and physical capabilities; (2) perception of antidepressants; (3) fears; (4) intrinsic motivators and goals; (5) the Doctor as a navigator to maintenance or discontinuation; (6) perceived cause of depression; (7) aspects of information that support decision-making; (8) significant others - a help or a hindrance; and (9) support from other health professionals.

Limitations: Coding and development of subthemes and themes was performed by one researcher and further developed through discussion between two researchers.

Conclusions: Barriers and facilitators to discontinuing antidepressant use are numerous and complex, and likely to require detailed conversations between patients and their general practitioners (GPs). These conversations are more likely to happen if GPs raise the issue of discontinuation. Further research from a health professional perspective including, but not limited to GPs, is needed.

Citing Articles

Predicting intentions towards long-term antidepressant use in the management of people with depression in primary care: A longitudinal survey study.

Dewar-Haggart R, Muller I, Bishop F, Geraghty A, Stuart B, Kendrick T PLoS One. 2025; 20(3):e0299676.

PMID: 40036220 PMC: 11878936. DOI: 10.1371/journal.pone.0299676.


Role of primary care in depression relapse: a qualitative study.

Moriarty A, Moriarty A, Williams E, McMillan D, Gilbody S, Chew-Graham C Br J Gen Pract. 2024; .

PMID: 39304309 PMC: 11881007. DOI: 10.3399/BJGP.2024.0384.


The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study.

Mahmood R, Wallace V, Wiles N, Kessler D, Button K, Fairchild G Health Expect. 2024; 27(1):e13966.

PMID: 39102706 PMC: 10774987. DOI: 10.1111/hex.13966.


Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial.

Kendrick T, Stuart B, Bowers H, Haji Sadeghi M, Page H, Dowrick C JAMA Netw Open. 2024; 7(6):e2418383.

PMID: 38913372 PMC: 11197448. DOI: 10.1001/jamanetworkopen.2024.18383.


Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy.

Vom Hofe I, Stricker B, Vernooij M, Ikram M, Ikram M, Wolters F Alzheimers Dement. 2024; 20(5):3378-3387.

PMID: 38561253 PMC: 11095425. DOI: 10.1002/alz.13807.